Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen.
暂无分享,去创建一个
Shyam Natarajan | Jiaoti Huang | Leonard S Marks | Geoffrey A Sonn | D. Margolis | G. Sonn | Jiaoti Huang | Edward F. Chang | R. Reiter | F. Dorey | L. Marks | Frederick J Dorey | Daniel J Margolis | S. Natarajan | Edward Chang | Malu Macairan | Patricia Lieu | Robert E Reiter | Patricia Lieu | M. Macairan
[1] Heinz-Peter Schlemmer,et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. , 2006, European urology.
[2] A. Haese*,et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. , 2006, European urology.
[3] P. Mozer,et al. Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. , 2012, European urology.
[4] W. Ellis,et al. Improved prostate cancer detection with anterior apical prostate biopsies. , 2006, Urologic oncology.
[5] Pingkun Yan,et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. , 2011, The Journal of urology.
[6] William J Catalona,et al. Serial biopsy results in prostate cancer screening study. , 2002, The Journal of urology.
[7] Roberto Passariello,et al. Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy , 2010, Clinical Cancer Research.
[8] J. Fütterer,et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. , 2013, European urology.
[9] M. Barry,et al. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. , 2007, Journal of the National Cancer Institute.
[10] P. Puppo. Repeated negative prostate biopsies with persistently elevated or rising PSA: a modern urologic dilemma. , 2007, European urology.
[11] Robert W Veltri,et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. , 2003, The Journal of urology.
[12] Case records of the Massachusetts General Hospital. Case 9-2012. A 67-year-old man with a persistently elevated PSA level. , 2012, The New England journal of medicine.
[13] Yipeng Hu,et al. Characterizing clinically significant prostate cancer using template prostate mapping biopsy. , 2011, The Journal of urology.
[14] Baris Turkbey,et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. , 2012, The Journal of urology.
[15] K. Fareed,et al. Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. , 2011, The Journal of urology.
[16] C C Schulman,et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? , 2001, The Journal of urology.
[17] Thomas Hambrock,et al. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. , 2012, European urology.
[18] Aaron Fenster,et al. Clinical application of a 3D ultrasound-guided prostate biopsy system. , 2011, Urologic oncology.
[19] Georgios Sakas,et al. A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. , 2011, The Journal of urology.
[20] K. Wallner,et al. The morbidity of transperineal template‐guided prostate mapping biopsy , 2008, BJU international.
[21] K. Wallner,et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting , 2009, Prostate Cancer and Prostatic Diseases.
[22] Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. , 2007, European urology.
[23] Monish Aron,et al. 3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. , 2012, The Journal of urology.
[24] Mark Emberton,et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.
[25] M. Melamed,et al. Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer. , 2012, The Journal of urology.
[26] Shyam Natarajan,et al. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. , 2013, The Journal of urology.
[27] Baris Turkbey,et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.
[28] Ralph Strecker,et al. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning. , 2011, Radiology.
[29] M. Terris,et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.
[30] Amy Blase,et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. , 2007, Urology.